and many others. The letter highlights the fact that the industry relies on the FDA’s regulatory framework, and that “judicial activism” undermines it.
“Adding regulatory uncertainty to the already inherently risky work of discovering and developing new medicines will likely have the effect of reducing incentives for investment, endangering the innovation that characterizes our industry,” they wrote.Pear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and insomnia, filed for bankruptcy last week, as the company struggled to get insurers to pay for its technology.
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Music Industry Moves: Khalid to Receive BMI Champion Award; Jonathan McHugh Joins AMR SongsKhalid will be honored with the BMI Champion Award at the 71st Annual BMI Pop Awards. The artist and songwriter will be celebrated for his artistry and philanthropic efforts. At the event, BMI’s Po… The hell is the Body Mass Index Pop Awards?
اقرأ أكثر »